The present invention relates to the use of microRNA-1236 for diagnosis and treatment of ovarian granulocyte cell cancer or endometrial cancer, specifically, modified FOXL2 of microRNA-1236 in ovarian granulocyte cell cancer or endometrial cancer cells. Upon confirming the selective degradation to mRNA, the composition comprising the anti-microRNA-1236 according to the present invention can prevent or treat ovarian granulocyte cell cancer and/or endometrial cancer, and the expression level of microRNA-1236 By confirming, it is expected to be useful for diagnosis of ovarian granulocyte cell cancer and/or endometrial cancer.
展开▼
